BetterLife Pharma Inc.
BETR
CNSX
| 07/31/2025 | 04/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 15.42% | -23.88% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.44% | -25.56% | |||
| Operating Income | -12.44% | 25.56% | |||
| Income Before Tax | -151.82% | 73.01% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -151.82% | 73.01% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 325.81% | -114.03% | |||
| Net Income | -141.87% | 71.26% | |||
| EBIT | -12.44% | 25.56% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -118.18% | 72.50% | |||
| Normalized Basic EPS | -25.00% | 65.71% | |||
| EPS Diluted | -71.43% | 76.27% | |||
| Normalized Diluted EPS | -25.00% | 65.71% | |||
| Average Basic Shares Outstanding | 15.07% | 0.43% | |||
| Average Diluted Shares Outstanding | 15.07% | 0.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||